Blocknomi
Key Highlights Pfizer (PFE) stock hovers around $26.78 following European regulatory acceptance of Lyme vaccine submission. Phase 3 VALOR trial demonstrated efficacy exceeding 70% for Pfizer’s Lyme disease vaccine candidate.…
Related articles
-
BNB Tops Grayscale’s Smart Contract Fund After Q2 Rebalance, Passing Ether and Solana
BlockchainReporter Published 06.08.2026 15:00
-
110 Billion Shiba Inu Netflow Signals Shifting Momentum
U.Today Published 08.08.2026 17:38
-
Nebius (NBIS) Stock Climbs 9.5% Following Strong Q2 Results and Analyst Upgrade
Blocknomi Published 12.08.2026 11:08
-
When crypto tax stops being a spreadsheet problem
Crypto.News Published 29.07.2026 17:35
-
U.S. Sends Reported Iran Peace Offer Through Qatar as Strike Risks Rise
Blocknomi Published 02.08.2026 02:48
-
Riot Platforms (RIOT) Shares Soar 25% Following Massive Anthropic Data Center Partnership
Blocknomi Published 11.08.2026 07:06
-
Zoomex Monthly Transparency Report: July 2026
BeInCrypto Published 06.08.2026 14:33
-
Coinbase Brings US Stocks to UK Amid Broader Finance Push
CryptoNewsZ Published 06.08.2026 13:28